Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2003
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370531A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1370528A1 Mch antagonists and their use in the treatment of obesity
12/17/2003EP1370525A1 Biguanide derivatives
12/17/2003EP1370523A1 Diphenyl derivatives
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370296A2 Catecholate beta-lactam conjugates, method for producing the same and the use thereof
12/17/2003EP1370289A2 Method for producing a vaccine containing autologous antibodies
12/17/2003EP1370279A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
12/17/2003EP1370276A2 Medical uses of intercellular communication facilitating compounds
12/17/2003EP1370269A2 Pharmaceutical composition for the treatment of diabetes comprising, a 5-phenoxyalkal-2,4-thiazolidinedione derivative and a compound which stimulates insulin secretion
12/17/2003EP1370260A2 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
12/17/2003EP1370256A1 Novel inhibitors of formation of advanced glycation endproducts (ages)
12/17/2003EP1370241A1 Multi-lamellar emulsion(mle) for stabilizing dermatologically useful ingredients and external base preparations for general skin diseases utilizing the same
12/17/2003EP1370159A1 Method for producing vitamin b-enriched preparations from grasses
12/17/2003EP1370148A1 Anticholesterolemic edible oil
12/17/2003EP1272470B1 Amorphous torasemide modification
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1142900B1 Siastatin b derivatives having glycosidase inhibitory activities and process for producing the same
12/17/2003EP1082302B1 A vla-4 inhibitor: omepupa-v
12/17/2003EP1001943B1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them
12/17/2003EP0980241B1 Gelatine encapsulated solution dosage forms of sertraline
12/17/2003EP0928196B1 Beta-glucan products and extraction processes from cereals
12/17/2003EP0552142B2 T cell receptor peptides as therapeutics for autoimmune and malignant disease
12/17/2003CN1462195A Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same
12/17/2003CN1462189A Midicial herbal compound for prevention and treatment of diabetes
12/17/2003CN1461754A Telerance starch made of starch of de-amylopectin by iso-anylase
12/17/2003CN1461656A Medicinal excipient-potassium alginate and its composition
12/17/2003CN1461641A Calcium supplementing agent and its prepn. method
12/17/2003CN1131230C Tricyclic delta 3-piperidines as alpha 2-antagonists
12/17/2003CN1131225C Novel polyoxypropylenpolyoxyethylene vitamin E and preparation thereof
12/17/2003CN1131222C Benzamide derivs and their use as APOB-100 secretion inhibitors
12/17/2003CN1131056C Hypoglycemic deep-rooted ulcer eliminating medicine
12/17/2003CN1131053C Chinese medicine for treating diabetes
12/17/2003CN1131050C Medicinal particles for treating diabetic preipheral nearopathy and preparation method thereof
12/17/2003CN1131041C Preparing process for instant aminoacid-calcium particles
12/17/2003CN1131029C Application of dihydromyricetrin in medicine for preparation of hepatitis
12/17/2003CN1130986C Health-care product for reducing blood fat and sugar and delaying sanility
12/16/2003US6664420 For therapy of hypertension, type 2 insulin-resistant diabetes mellitus, ecalmpsia and preeclampsia
12/16/2003US6664389 Highly resistant granular starch
12/16/2003US6664273 Having at least cyanobenzyl and amidobenzyl substituents; obesity, metabolic disorders, eating disorders such as hyperphagia and diabetes
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6664236 Mixtures of glucosides obtained by solvent extraction from plants, comprising barlerin, acetyl barlerin, shanshizide methyl esters and adjuvants, used for detoxification, immunomodulation and as anxiolytic agents
12/16/2003US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
12/16/2003US6663878 Anti-inflammatory bioactive glass particulates
12/16/2003CA2124578C A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses
12/11/2003WO2003102240A1 A method for identification of obese il-6 responsive patients
12/11/2003WO2003102237A1 Treatment with cytokines
12/11/2003WO2003102206A2 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003WO2003102180A1 NOVEL PEPTIDES HAVING cAMP PRODUCING ACTIVITY
12/11/2003WO2003102163A2 Methods of diagnosing and treating diabetes and insulin resistance
12/11/2003WO2003102138A2 Elongase genes and uses thereof
12/11/2003WO2003102116A2 Oil-soluble pigment compositions
12/11/2003WO2003101991A1 Xanthine phosphodiesterase v inhibitor polymorphs
12/11/2003WO2003101988A2 Compounds and compositions for the treatment of diabetes and diabetes-related disorders
12/11/2003WO2003101987A1 3-substituted quinuclidines and their use
12/11/2003WO2003101984A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
12/11/2003WO2003101983A1 Tetrahydropyran derivative
12/11/2003WO2003101981A1 Novel substituted indoles
12/11/2003WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
12/11/2003WO2003101978A1 Phenyl-thiophene type vitamin d receptor modulators
12/11/2003WO2003101970A1 Imidazolium cxcr3 inhibitors
12/11/2003WO2003101964A1 Piperidine derivative, process for producing the same, and use
12/11/2003WO2003101963A1 Opioid receptor antagonists
12/11/2003WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003WO2003101945A1 Ligands that are inhibitors of the rar receptors
12/11/2003WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003WO2003101927A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
12/11/2003WO2003101923A2 Policosanol compositions, extraction from novel sources, and uses thereof
12/11/2003WO2003101490A1 Drug composition containing calcium channel antagonist
12/11/2003WO2003101456A1 Use of compounds that stimulate cgmp
12/11/2003WO2003101455A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/11/2003WO2003101454A1 A buffered, liquid nicotine composition for pulmonary administration
12/11/2003WO2003101453A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/11/2003WO2003101450A1 N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris
12/11/2003WO2003101449A2 Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
12/11/2003WO2003101448A1 The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
12/11/2003WO2003101436A1 Novel chromium (iii) alpha amino acid complexes
12/11/2003WO2003101376A2 Topical use of at least one double-stranded rna oligonucleotide (ds rna)
12/11/2003WO2003101224A1 Dietary method for modulatng glucose metabolism and associated conditions and increasing longevity
12/11/2003WO2003101177A2 Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
12/11/2003WO2003080566A3 Hif hydroxylase inhibitors
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2003057235A3 Modification of feeding behavior
12/11/2003WO2003053163A3 Salt composition with low sodium chloride and high organic potassium salt content and uses thereof
12/11/2003WO2003048117A3 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
12/11/2003WO2003038037A3 Glycogen synthase kinase function in endothelial cells
12/11/2003WO2003037166A3 Devices and methods for the restoration of a spinal disc
12/11/2003WO2003034996A3 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
12/11/2003WO2003027090A3 Bicyclic heterocycles as rxr ligands
12/11/2003WO2003026579A3 Combination therapies for immune mediated diseases
12/11/2003WO2003024395A3 Linked biaryl compounds
12/11/2003WO2003022216A3 Biaryl substituted purine derivatives as potent antiproliferative agents
12/11/2003WO2003013569A3 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
12/11/2003WO2002089853A3 Compositions having enhanced pharmacokinetic characteristics
12/11/2003WO2002085925A3 Melanocortin receptor ligands
12/11/2003WO2002083841A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
1 ... 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 ... 1298